A Validated High-Performance Liquid Chromatographic Method for the Determination of Acebutolol and Diacetolol in Human Plasma
- 1 December 1992
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 15 (18) , 3233-3245
- https://doi.org/10.1080/10826079208020881
Abstract
A validated high-performance liquid chromatographic (HPLC) procedure employing ultra-violet (UV) detection for the analysis of acebutolol (Monitan) and its major metabolite, diacetolol, in human plasma in reported. The method is rapid and coupled with standard HPLC procedures leads to a sensitive, accurate, and reproducible assay. The retention times of diacetolol, acebutolol and internal standard, celiprolol, were 4.1, 6.7 and 9.7 minutes, respectively. The peak height versus plasma concentration is linear over the range of 20.0 to 1000 ng/mL for each analyte, with a detection limit of 10.0 ng/mL. The mean absolute recovery of acebutolol and diacetolol using the described assay is 74.6 and 88.8%, respectively. The inter- and intra-day accuracy and precision are within 14.1% of the actual values for all concentrations investigated. Furthermore, this procedure is applied to assess the pharmacokinetics of a single 200 mg oral dose of Monitan.Keywords
This publication has 4 references indexed in Scilit:
- Acebutolol: A Review of its Pharmacology, Pharmacokinetics, Clinical Uses, and Adverse EffectsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1986
- High-performance liquid chromatography assay of acebutolol and two of its metabolites in plasma and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1982
- Evaluation of a modified high-performance liquid chromatography assay for acebutolol and its major metaboliteJournal of Chromatography B: Biomedical Sciences and Applications, 1979
- Observations on the pharmacokinetics of acebutololClinical Pharmacology & Therapeutics, 1976